TABLE 1.
Differentially expressed characterized genes comparing grade 3 and normal valves with high stringency criteria (FDR Q-value < 0.1).
Gene symbol | Description | Fold change | Gene symbol | Description | Fold change |
NT5E | 5-nucleotidase, ecto (CD73) | –2.93 | ACYP2 | Acylphosphatase 2, muscle type | 1.63 |
TANC2 | Tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 2 | –1.72 | BNC2 | Basonuclin 2 | 1.82 |
CCDC65 | Coiled-coil domain containing 65 | –1.69 | NOV | Nephroblastoma overexpressed | 1.87 |
ENPP2 | Ectonucleotide pyrophosphatase/phosphodiesterase 2 | –1.64 | CDKN2B | Cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4) | 1.94 |
LOC 102152842 | Zinc finger protein 512-like | –1.51 | PLCXD3 | Phosphatidylinositol-specific phospholipase C, X domain containing 3 | 2.98 |
LOC 480571 | Septin-4 | 1.51 | CDKN2A | Cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4) | 5.34 |
UBTD1 | Ubiquitin domain containing 1 | 1.55 | LRRN1 | Leucine rich repeat neuronal 1 | 6.1 |
FAM174A | Family with sequence similarity 174, member A | 1.58 | CDKN2A | Cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4) | 7.79 |
Genes appearing more than once were represented by more than one probe set on the array.